ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: PP03

Lupus with Slime: Improve QOL and Increase ROM in SLE with Slime

Amanda Greene, Los Angeles, CA

Meeting: ACR Convergence 2023

Keywords: mental health, Occupational therapy, quality of life, range of motion, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 12, 2023

Title: Patient Perspectives Poster

Session Type: Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: In 1983, over forty years ago, I was diagnosed with Systemic Lupus Erythematosus (SLE).  I was immediately prescribed high dose corticosteroids.  My body and disease flared.  After 16 months, the rheumatologist and internist decided to start to taper my medication dosage.  I was stabilized at 20, 15, 12.5 and 10m milligram daily doses.  However, the side effects were still drastic, and I wanted to see how well I would do at a lower dose.  So together with my doctors, I started a slow (super slow) taper process.  Eventually, I was taking 2.5 milligrams of steroids a day.  After three months, we discussed another tapering.  It took another three months, in 1989 I took my last dose of corticosteroids.  At the time, my doctors thought I would have a potential future need for another round of corticosteroids, as most people living with lupus do.  My prognosis at the time of diagnosis was a life expectancy of 5-7 years based on my symptoms and lab work.

Intervention: During the intervention, and while I was in lockdown, I was struggling to balance my mental and physical health, when I discovered how slime could help me stretch my mind and body.  I quickly realized how much I needed the tactile sensation and distraction; the slime had helped me regain my sense of play and I was captivated by the autonomous sensory meridian response (ASMR) that popping slime provided.  With some practice, I was doing tricks and I saw my outstretched arms and shoulders above my head, even better I was not wincing in agony.  My Range Of Motion (ROM) was increasing with each session and I was thoroughly enjoying my self, while the slime was providing me with quality occupational therapy, I was improving my Quality of Life (QOL) and the impact on my state of mind which is evident in the “countless smiles that smile has brought to my face.”  Slime has had a such positive impact on my life that I am using less prescription pain and anxiety medication to help maintain my healthy “flare free” state while living and thriving with SLE for 40 years and still striving.

Maintenance: Due to my use of slime as a tool for my mental and physical health, I am using less prescription pain and anxiety medication to maintain a healthy state of aging with while living with SLE and I am a proud “adult slimer” who has found a way to quantify my playtime as being truly good for my health.

Quality of Life: Due to my use of slime as a tool for my mental and physical health, I am using less prescription pain and anxiety medication to maintain a healthy state of aging with while living with SLE and I am a proud “adult slimer” who has found a way to quantify my playtime as being truly good for my health.

Supporting image 1

While living with Lupus using slime has a positive impact on both my physical and mental health.

Supporting image 2

Stepping into slime requires strength, stability and balance.

Supporting image 3

Stretching slime, opens up my ROM and I have discovered countless smiles and reduced anxiety due to the essential oils that enhance the sensations and tactile joy.


Disclosures: A. Greene: None.

To cite this abstract in AMA style:

Greene A. Lupus with Slime: Improve QOL and Increase ROM in SLE with Slime [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/lupus-with-slime-improve-qol-and-increase-rom-in-sle-with-slime/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/lupus-with-slime-improve-qol-and-increase-rom-in-sle-with-slime/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology